Scanning the Genome: SNP Mapping and GWAs Quiz

A single nucleotide polymorphism is a position in the genome where a single nucleotide differs between individuals, with the less common variant present in at least 1 percent of the population. SNPs are the most abundant form of genetic variation in the human genome, with an estimated 4 to 5 million common SNPs. They serve as molecular markers for genetic mapping, population genetics, and disease association studies because of their high density, stability, and ease of genotyping using modern high-throughput platforms.

A genome-wide association study scans the genomes of large numbers of case individuals who have a particular disease or trait and compares SNP frequencies with those from matched control individuals who do not. SNPs that are significantly more frequent in cases than controls are statistically associated with the trait. These associated SNPs typically tag a chromosomal region rather than the causal variant directly, and follow-up fine mapping and functional studies are required to identify the specific variant driving the association.

In GWAS, the strength of the association between a SNP and a trait is most commonly expressed as an odds ratio, which quantifies how much more likely individuals carrying the risk allele are to have the trait compared to those who do not. The statistical significance is reported as a p-value, and genome-wide significance is typically set at a threshold of 5 times 10 to the negative 8 to correct for the large number of simultaneous statistical tests performed across millions of SNPs in a single study.

Linkage disequilibrium refers to the non-random association between alleles at two or more loci in a population, meaning certain allele combinations occur together more frequently than expected by chance. In SNP mapping and GWAS, high LD between markers means that genotyping one SNP provides information about nearby ungenotyped variants because they are co-inherited in the same haplotype block. LD structure allows researchers to use a subset of tag SNPs to capture the majority of common genetic variation across the genome efficiently.

SNPs are the most abundant genetic variant type in the human genome and can be assayed simultaneously across millions of positions using high-throughput SNP microarray platforms. Through linkage disequilibrium, a typed SNP can tag nearby untested causal variants, making comprehensive coverage of the genome achievable without sequencing every base pair. Most SNPs are not in coding regions and do not directly alter protein sequence, making option C incorrect and highlighting that most GWAS signals require further characterization to identify functional variants.

GWAS identifies genomic regions statistically associated with a trait but does not directly pinpoint the causal variant. The associated SNP is usually a tag marker in linkage disequilibrium with one or more nearby variants. Multiple candidate variants in the same haplotype block may share a similar association signal. Functional follow-up studies, including fine mapping, expression quantitative trait locus analysis, gene editing, and in vitro functional assays, are required to determine which specific variant is biologically responsible for the observed association.

A Manhattan plot displays the statistical association results of a GWAS, with each point representing a SNP plotted by its chromosomal position on the horizontal axis and its negative log10 p-value on the vertical axis. The plot resembles the Manhattan skyline due to the many peaks across chromosomes. Peaks that rise above the genome-wide significance threshold of negative log10 p-value approximately equal to 7.3, corresponding to a p-value of 5 times 10 to the negative 8, indicate SNPs with statistically robust associations with the trait being studied.

A haplotype block is a chromosomal region in which specific combinations of SNP alleles tend to be inherited together as a unit across generations because recombination within that block has been historically rare. SNPs within a haplotype block are in high linkage disequilibrium with one another. Genotyping a single tag SNP within a block captures information about all other SNPs in that block without needing to genotype each one individually, which is the basis for efficient genome-wide association study design using SNP arrays.

Population stratification is a major potential confound in GWAS. If the case group has a different ancestral background than the control group, many SNPs will differ in allele frequency between the groups simply because of ancestry differences rather than any biological relationship with the trait. This can produce false positive associations across the genome. Principal component analysis of genome-wide SNP data is routinely used to detect and correct for population stratification, ensuring that associations reflect true biological signals.

Because GWAS tests millions of SNPs simultaneously, a stringent p-value threshold reduces but does not eliminate the chance of false positives. Replication in an independent cohort of similar ancestry and phenotype definition is considered essential to confirm that a genome-wide significant association is real. When a SNP association is replicated in one or more independent datasets, the likelihood that it represents a genuine biological link to the trait increases dramatically, supporting its inclusion in meta-analyses and downstream functional investigation.

GWAS identifies genomic regions tagged by associated SNPs rather than causal variants directly. It is most effective at detecting common genetic variants and has limited power to identify rare variants with minor allele frequencies below 1 to 5 percent. GWAS findings are also population-specific due to differences in LD structure and allele frequencies across ancestries, which limits generalizability. Most GWAS signals do not fall in protein-coding regions but in regulatory sequences, making option D incorrect and underscoring the need for functional follow-up.

An expression quantitative trait locus is a genomic position where genetic variation, typically a SNP, is statistically associated with differences in the mRNA expression level of a nearby gene in cis or a distant gene in trans. When a GWAS signal overlaps with an eQTL for a particular gene, it provides evidence that the associated SNP may influence disease risk by altering the expression of that gene rather than changing its protein sequence. Integrating eQTL data with GWAS results is a powerful strategy for prioritizing candidate causal genes within associated genomic regions.

Standard GWAS designs are optimized to detect common variants, generally defined as those with a minor allele frequency above 1 to 5 percent. A SNP with a minor allele frequency of 0.005, or 0.5 percent, is considered a rare variant and would be severely underpowered in a standard GWAS because too few individuals in typical study cohorts would carry the minor allele to provide sufficient statistical power. Rare variant detection requires alternative approaches such as whole-genome sequencing combined with burden tests or aggregation-based statistical methods.

Meta-analysis combines summary-level GWAS statistics, such as effect sizes and standard errors, from multiple independent cohorts to substantially increase sample size and statistical power. This approach allows detection of genetic associations with smaller effect sizes that would not reach genome-wide significance in any single cohort. Large-scale GWAS meta-analyses involving hundreds of thousands of participants have identified thousands of robustly associated loci for complex traits such as height, body mass index, type 2 diabetes, and coronary artery disease.

Linkage disequilibrium is central to GWAS: tag SNPs capture information about nearby variants through LD, and the associated SNP detected in GWAS is usually in LD with the true causal variant rather than being causal itself. Fine mapping uses LD structure to narrow the candidate region. If all SNPs across the genome were in perfect LD, it would actually reduce the number of tests needed rather than making GWAS impossible, making option C incorrect. Variation in LD across the genome is what allows both efficient tagging and fine mapping.